Detalhe da pesquisa
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126318
2.
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Blood
; 139(16): 2499-2511, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995350
3.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572549
4.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050405
5.
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Haematologica
; 108(1): 22-33, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545919
6.
Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin's Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient.
Medicina (Kaunas)
; 59(7)2023 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37512086
7.
Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report.
Medicina (Kaunas)
; 59(6)2023 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37374253
8.
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA.
Blood
; 139(10): 1588-1592, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34748627
9.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
10.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702878
11.
SARS-CoV-2 mutant spectra as variant of concern nurseries: endless variation?
Front Microbiol
; 15: 1358258, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38559344
12.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966980
13.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533127
14.
Feasibility of Telemedicine in the Management Strategy of Patients With Lymphoma Amid the COVID-19 Pandemic in Spain: Prospective Observational Study.
JMIR Form Res
; 7: e34128, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645838
15.
Frailty assessment to individualize treatment in older patients with lymphoma.
Eur Geriatr Med
; 14(6): 1393-1402, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823983
16.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923264
17.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911708
18.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005697
19.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv
; 7(11): 2645-2655, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058479
20.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine
; 58: 101939, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041967